1982
DOI: 10.1016/0006-2952(82)90641-4
|View full text |Cite
|
Sign up to set email alerts
|

Effects of the chiral isomers of erythro- and threo-9-(2-hydroxy-3-nonyl)adenine on purine metabolism in sarcoma 180 cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

1983
1983
2012
2012

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 14 publications
0
3
0
Order By: Relevance
“…We blocked adenosine deaminase (ADA), the enzyme that converts adenosine to inosine within the cells, with pharmacological inhibitor EHNA [18, 19]. As expected, EHNA did not reduce the protective effect of inosine or glucose but significantly decreased the viability of the adenosine treated cells subjected to OGD and also significantly increased the LDH release from the cells (Fig.…”
Section: Resultsmentioning
confidence: 88%
“…We blocked adenosine deaminase (ADA), the enzyme that converts adenosine to inosine within the cells, with pharmacological inhibitor EHNA [18, 19]. As expected, EHNA did not reduce the protective effect of inosine or glucose but significantly decreased the viability of the adenosine treated cells subjected to OGD and also significantly increased the LDH release from the cells (Fig.…”
Section: Resultsmentioning
confidence: 88%
“…Anal. 9-[l-Fluoro-2(fl)-octyl]adenine (23). To a cold (-78 °C) solution of (diethylamido)sulfur trifluoride (DAST, 0.15 mL, 1.14 mmol) in CH2C12 (3 mL) was slowly added a solution of 22 (113 mg, 0.430 mmol) in anhydrous CH2C12 (3 mL), and stirring was continued for 1 h. After stirring for 1 h at room temperature, excess DAST was decomposed by the careful addition of cold saturated solution of NaHC03 (5 mL).…”
Section: -[L^(sf)-(isopropylidenedioxy)-3(fi)-nonyl]adenine(13)mentioning
confidence: 99%
“…(13) Gieger, J. D.; Lewis, J. L.; MacIntyre, C. J.; Nagy, J. (+)-EHNA (+)-2S,3fi isomer as the most potent ADA inhibitor.21 (+)-EHNA proved to be the most active isomer in the enhancement of oro-A activity against human pancreatic and colon carcinomas.22 All four stereoisomers caused similar inhibition of purine biosynthesis in sarcoma 180 cells, but these effects were not pronounced below drug concentrations of 1 x 10~* ***5 M. 23 The comparable anti-HSV activity of all four isomers suggests that the antiviral activity is not mediated through inhibition of ADA. 24 Recently, an apparent isoenzyme of ADA had been identified, ADA2.…”
Section: Introductionmentioning
confidence: 99%